Blockchain in Genomics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Business Model (B2B Business Model, B2C Business Model, and C2B Business Model), By Service (Utility Tokens and Blockchain Platforms), By Application (Data Sharing & Monetization, Data Storage & Security, and Automated Health Insurance), By End User (Pharmaceutical & Biotechnology Companies, Hospitals & Healthcare Providers, Research Institutes, Data Owners, And Others), By Region and Competition, 2020-2030F

Market Overview

Global Blockchain in Genomics Market was valued at USD 1.06 Billion in 2024 and is anticipated to project robust growth in the forecast period with a CAGR of 11.11% through 2030. Blockchain is a digital public ledger that securely records transactions and data in units known as blocks. For instane, in 2022, the FDA’s Center for Drug Evaluation and Research (CDER) approved 37 new molecular entities (NMEs). Of the 35 therapeutic NMEs, 12—around 34 percent—were classified as personalized medicines by the Personalized Medicine Coalition (PMC). This highlights the growing emphasis on tailoring treatments based on individual genetic, biomarker, or molecular profiles to improve therapeutic outcomes and reduce adverse effects. Each block is timestamped and linked to the previous one, forming an immutable chain that cannot be altered retroactively. This decentralized framework allows data to be distributed across a network of interconnected systems without relying on a central authority, enhancing transparency and reliability. With global accessibility enabled through proper authorization, users maintain control over their data, ensuring privacy and security.

Blockchain uses asymmetric cryptography to encrypt data, allowing only intended recipients with a private key to decrypt and access information. This mechanism is particularly useful when individuals choose to sell or donate their data, as it prevents unauthorized access by third parties. In the field of genomics, blockchain is instrumental in the secure storage, management, and sharing of sensitive genomic data. Its decentralized structure benefits industries such as banking, finance, biopharmaceuticals, and research. In genomics, for example, it supports secure transactions between data owners and buyers like pharmaceutical companies or research institutions. By fostering direct communication between these stakeholders, blockchain facilitates informed decision-making, enhances trust, and promotes more efficient, secure data exchange practices.

Key Market Drivers

Rising Investment by Private Players and Venture Capitalists

Increased investment provides researchers and innovators with the financial resources needed to explore and develop blockchain solutions tailored for genomics. This funding supports the creation of new platforms, tools, and applications that leverage blockchain's capabilities. For instance, in March 2024, MENADNA Inc., a prominent bioinformatics and genetic testing startup focused on the Middle East and North Africa (MENA) region, announced an exclusive partnership with Nebula Genomics, a leader in personalized genome sequencing. Under this agreement, MENADNA becomes Nebula's exclusive partner in Jordan, Oman, and Iraq. Currently active in the UAE, MENADNA also plans to expand into Saudi Arabia. The collaboration aims to enhance the region’s representation in genomic research by combining Nebula’s cutting-edge sequencing technology with MENADNA’s proprietary bioinformatics platform, addressing a long-standing gap in global genome-wide association studies.  Financial support from private players and venture capitalists accelerates the development of blockchain-based solutions for genomics. This leads to quicker advancements in technology, making blockchain more accessible and applicable to genomic research and data management. Funding supports the development of robust and scalable blockchain infrastructure required to handle large volumes of genomic data securely. This infrastructure enables efficient data storage, sharing, and analysis. Investments attract collaboration among stakeholders, including researchers, industry players, technology providers, and healthcare institutions. These partnerships foster a collaborative ecosystem that accelerates blockchain adoption in genomics. Venture capital investment fuels the growth of genomics-focused start-ups that are developing blockchain solutions. These start-ups contribute to the development of new platforms, tools, and applications, increasing the overall demand for blockchain technology. Investment in blockchain technology enables the streamlining of clinical trials, data sharing, and research collaboration. This leads to more efficient and cost-effective research efforts in genomics. Increasing investments from private players and venture capitalists are contributing to the growth of the Blockchain in Genomic Data Management Market. Recent developments in this field, such as strategic partnerships involving pharmaceutical companies and government bodies, as well as investments from venture capital and other stakeholders, indicate the growing acceptance of blockchain platforms for the storage and management of genetic information in the healthcare industry. These collective efforts will significantly drive the market's growth in the years to come.

Increasing Developments in Genomics

According to the National Centre for Science and Engineering Statistics, academic institutions in the United States invested a record USD 97.8 billion in research and development (R&D) during fiscal year 2022—an increase of USD 8.0 billion from 2021. This surge in funding reflects a growing commitment to scientific innovation, with a significant portion directed toward advancing genomic research and personalized medicine initiatives across academic settings. Genomic data is highly sensitive and personal, containing valuable information about an individual's health and genetic makeup. Blockchain's decentralized and secure nature can help protect genomic data from unauthorized access and breaches, ensuring patient privacy.  Blockchain can empower individuals to have greater control over their genomic data. Patients can grant or revoke access to their data on a permissioned basis, enabling them to share data with researchers or healthcare providers while maintaining ownership. Genomic research often involves data sharing and collaboration among different organizations and institutions. Blockchain can establish a secure and transparent platform for sharing and accessing genomic data across multiple entities while maintaining data integrity. Blockchain's immutability ensures that once data is recorded, it cannot be altered or deleted without consensus from the network. This feature is particularly important for maintaining the accuracy and reliability of genomic data over time.

Rising Adoption of Digital Tools

The rising adoption of digital tools in blockchain technology within the field of genomics is transforming the way genetic data is managed, shared, and utilized. Digital tools are used to implement robust encryption and security measures for genomic data stored on the blockchain. This ensures that sensitive genetic information remains confidential and protected from unauthorized access. Digital tools enable the creation and management of decentralized identities for individuals participating in genomics research. These identities can control access to personal genomic data and streamline consent processes. Digital tools can establish standardized formats and metadata for genomic data stored on the blockchain. This ensures consistency and facilitates efficient data retrieval and analysis. Digital tools enable secure and controlled sharing of genomic data among researchers, healthcare providers, and patients. Participants can define access permissions and track data usage transparently. Digital tools can be employed to verify the integrity of genomic data by recording data hashes or digital signatures on the blockchain. This helps ensure that data has not been tampered with or altered. Digital tools enable real-time tracking of data transactions and movements on the blockchain. This transparency enhances accountability and traceability of data usage.

Digitization Of Healthcare Services by Patients

Blockchain technology has emerged as a viable option for storing and exchanging genomic data. The decentralized information management model used in blockchains has shown significant benefits in the banking and fintech industries. The cryptocurrencies based on blockchain technology are viewed as powerful tools for peer-to-peer transactions, eliminating the need for a third party to oversee exchanges. In genomics, blockchain can serve as a trusted means of conducting transactions between data owners and users, such as research groups and pharmaceutical companies. These platforms also facilitate easy access to genomic datasets, greatly improving the information procurement process for personalized drug and therapy research studies. Consequently, numerous companies have initiated efforts to promote the use of blockchain technology for managing genomic data. The growing significance of blockchain in managing genetic information and its application in healthcare decision-making is evident from the substantial number of tweets (~1,750) posted on Twitter in recent years. Notably, the establishment of strategic partnerships involving pharmaceutical players and relevant government bodies, as well as investments by venture capital and other stakeholders, indicate the increasing acceptance of blockchain platforms for the storage and management of genetic information in the healthcare industry.

Download Free Sample Report

Key Market Challenges

Regulatory Challenges

The use of blockchain technology in genomics presents several regulatory challenges that need to be addressed to ensure compliance with existing laws and ethical standards. These challenges stem from the unique nature of genomic data, data privacy concerns, data ownership, and the decentralized nature of blockchain. Genomic data is highly sensitive and personal. Regulatory frameworks, such as the General Data Protection Regulation (GDPR) in the European Union, require strict adherence to data privacy principles. Ensuring that individuals provide informed and explicit consent for their data to be stored, shared, and used on the blockchain is a significant challenge. Blockchain's decentralized nature challenges traditional concepts of data ownership. Determining who has control over genomic data stored on the blockchain and how individuals can assert their rights over their data is a regulatory hurdle. Integrating blockchain into existing regulatory frameworks designed for centralized systems can be difficult. Regulators must adapt or create new regulations that accommodate the unique characteristics of blockchain technology.

Lack of Resources and Stakeholders

The lack of resources and stakeholders in the adoption of blockchain technology in genomics possess significant challenges that hinder its growth and implementation. These challenges can impact the development, deployment, and sustainability of blockchain-based solutions in genomics. Developing and implementing blockchain solutions requires significant financial investment. Lack of funding can impede the development of robust and secure blockchain platforms for managing genomic data. Blockchain technology is complex and requires specialized technical expertise in areas such as cryptography, blockchain architecture, and smart contract development. The scarcity of skilled professionals can hinder the successful implementation of blockchain solutions in genomics. Blockchain networks require robust and scalable infrastructure to ensure optimal performance, data storage, and network consensus. Limited access to suitable infrastructure can hinder the deployment of blockchain solutions in genomics. Blockchain solutions in genomics require standardized data formats, terminologies, and metadata to ensure interoperability and data integrity. The lack of established standards can complicate data integration and sharing.

Key Market Trends

Innovations in Technology

Innovation in blockchain technology within the field of genomics has the potential to significantly boost its demand in the future by addressing existing challenges, enhancing data management, improving research collaboration, and enabling new possibilities for personalized medicine. Innovative blockchain solutions can offer even stronger data security and privacy features, assuaging concerns about the safe storage and sharing of sensitive genomic data. This can encourage more individuals to contribute their data for research and clinical purposes. Blockchain innovations can introduce advanced consent management and data ownership mechanisms. Individuals will have greater control over their genetic data, leading to increased willingness to participate in research initiatives. Innovative blockchain platforms can facilitate secure cross-border data sharing and collaboration among researchers and institutions. This can accelerate the pace of genomics research by allowing global participation and knowledge exchange. As blockchain technology continues to evolve and new innovations emerge, the demand for its integration in genomics is likely to grow. These innovations can address critical concerns, unlock new research opportunities, and ultimately lead to improved patient care, driving the adoption and utilization of blockchain technology in the field of genomics.

Launch of New Blockchain-Based Platforms

The launch of new blockchain-based platforms specifically tailored for genomics can indeed play a significant role in boosting the demand for blockchain technology within the genomics field. These platforms can address key challenges, provide specialized solutions, and create a conducive environment for data sharing, research collaboration, and personalized medicine. New blockchain-based platforms can offer customized data management solutions designed specifically for genomics data. These platforms can ensure secure and efficient storage, sharing, and tracking of genomic information, enhancing data integrity and privacy. Dedicated genomics platforms can integrate advanced privacy features and consent management mechanisms, alleviating concerns about data security and giving individuals more control over how their genetic data is used. These platforms can facilitate the integration of diverse genomic datasets from different sources and formats, promoting data standardization and interoperability. This integration can accelerate research by providing a comprehensive view of genetic information.

Segmental Insights

Business Model Insights

Based on business model, the Business-to-Customer (B2C) segment holds significant potential in the global blockchain in genomics market due to the growing consumer interest in personal health data and direct-to-consumer genetic testing. Individuals are increasingly seeking control over their genomic information, and blockchain enables secure, private, and transparent data management. Through blockchain platforms, customers can store their genetic data securely and decide who accesses it, when, and for what purpose, using encrypted keys. In the B2C model, consumers interact directly with genomic service providers without intermediaries. This fosters trust and transparency while giving users the option to monetize or donate their data to research organizations or pharmaceutical companies. The B2C segment is also driven by rising awareness of personalized medicine, ancestry testing, and preventive healthcare. Companies offer users rewards or tokens in exchange for sharing genomic data, further incentivizing participation. Blockchain empowers consumers with ownership of their data, which is crucial in a data-sensitive field like genomics. As privacy concerns and demand for transparency increase, the B2C segment is expected to grow, enabling a more ethical, user-centric approach to genomic data utilization.

Application Insights

In terms of application, the  data sharing & monetization dominates the global blockchain in genomics market due to its ability to address key challenges related to privacy, ownership, and value extraction from genomic data. Traditional data-sharing methods often lack transparency and expose individuals to risks of misuse or unauthorized access. Blockchain solves these issues by providing a secure, decentralized platform where data is encrypted, traceable, and accessed only with user consent. This segment is crucial because it empowers individuals to control and monetize their genomic information. Through blockchain-based platforms, users can choose to share their data with research institutions, pharmaceutical companies, or biotech firms in exchange for compensation, such as cryptocurrency or tokens. This model not only promotes individual data ownership but also fuels the growth of genomic research by making diverse datasets more readily available. As the demand for personalized medicine and advanced research increases, so does the need for high-quality genomic data. Blockchain facilitates ethical data sharing at scale, while maintaining trust and transparency. As a result, the Data Sharing & Monetization segment stands out as a key driver of innovation, user engagement, and commercial opportunity in the blockchain genomics ecosystem.

Download Free Sample Report

Regional Insights

In the global market, the North America blockchain in genomics market emerged as the leader in 2024. This can be attributed to several favorable factors. Key drivers for the regional market revenue growth include the rising prevalence of genetic disorders, increasing research and development activities in genomics, rapid adoption of blockchain technology in the field, growing government investments in healthcare research and development, and the presence of prominent market players in the region such as GenoBank.io Inc., LunaDNA, Longenesis Ltd., and Nebula Genomics, Inc.

Recent Developments

• In June 2025, XRP Ledger expanded into the genomics sector by introducing a Blockchain Identity Mesh. This innovative move aims to enhance data ownership, privacy, and interoperability in genomic research. By leveraging decentralized identity and blockchain technology, the initiative empowers individuals to securely control and share their genomic data. This marks a significant step toward integrating blockchain solutions within personalized medicine and genomic data ecosystems. 
• In February 2025, Nasdaq-listed Prenetics announced a genomics-focused partnership with Humanity Protocol, aiming to integrate secure digital identity with personalized health data. As part of this initiative, Prenetics also launched a crypto strategic reserve to support blockchain-driven healthcare innovation. This move highlights the company’s commitment to combining genomics and Web3 technologies, enhancing data privacy, ownership, and accessibility in the evolving digital health ecosystem.
• According to an April 2025 article, blockchain projects are competing to secure 23andMe user data as the company faces bankruptcy. Amid rising concerns, privacy advocates and government officials are urging users to delete their genetic information. Meanwhile, blockchain developers see an opportunity to shift genomics data onchain, promoting secure, user-owned data models in response to growing distrust in centralized genetic testing platforms.
• In September 2020, Nebula Genomics announced its partnership with Oasis Labs to implement an innovative framework for the secure utilization of personal genomics data. This collaboration also enables unprecedented access to genetic data for customers. Through this strategic alliance, Nebula aims to fortify its market presence.
• In September 2019, Digital DNAtix Ltd introduced the pioneering concept of a free and anonymous genetic vault service. This groundbreaking service empowers users to engage directly, pose inquiries, connect with individuals sharing similar traits, gain valuable insights, and contribute to a comprehensive database of genetic information that facilitates open exchange.
• In September 2019, Nebula Genomics, Inc. launched blockchain-based DNA sequencing, a revolutionary advancement in the field. By integrating blockchain technology into DNA sequencing, the company is poised to enhance its competitive position and further establish its foothold in the market.

Key Market Player

•  Oxford Nanopore Technologies Plc
• PacBio (Pacific Biosciences of California Inc.)
• Guardtime Ltd.
• Agilent Technologies Inc.
• Illumina Inc.
• BioRad Laboratories Inc.
• 10x Genomics Inc.
• QIAGEN NV
• Nebula Genomics Inc.
• Thermo Fisher Scientific.

Report Scope:

In this report, the Global Blockchain in Genomics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• Blockchain in Genomics Market, By Business Model:

o   B2B Business Model

o   B2C Business Model

o   C2B Business Model

• Blockchain in Genomics Market, By Service:

o   Utility Tokens

o   Blockchain Platforms

• Blockchain in Genomics Market, By Application:

o   Data Sharing & Monetization

o   Data Storage & Security

o   Automated Health Insurance

• Blockchain in Genomics Market, By End User:

o   Pharmaceutical & Biotechnology Companies

o   Hospitals & Healthcare Providers

o   Research Institutes

o   Data Owners

o   Others

• Blockchain in Genomics Market, By Region:

o   North America

§  United States

§  Canada

§  Mexico

o   Europe

§  France

§  United Kingdom

§  Italy

§  Germany

§  Spain

o   Asia-Pacific

§  China

§  India

§  Japan

§  Australia

§  South Korea

o   South America

§  Brazil

§  Argentina

§  Colombia

o   Middle East & Africa

§  South Africa

§  Saudi Arabia

§  UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Blockchain in Genomics Market.

Available Customizations:

Global Blockchain in Genomics market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Global Blockchain in Genomics Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]